1,719
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Working smart: the use of ‘cognitive enhancers’ by UK university students

ORCID Icon, &
Pages 270-283 | Received 13 Dec 2018, Accepted 04 Apr 2020, Published online: 04 May 2020

References

  • Arria, A. M., H. C. Wilcox, K. M. Caldeira, K. B. Vincent, L. M. Garnier-Dykstra, and K. E. O’Grady. 2013. “Dispelling the Myth of ‘Smart Drugs’: Cannabis and Alcohol Use Problems Predict Nonmedical Use of Prescription Stimulants for Studying.” Addictive Behaviours 38: 1643–1650. doi:10.1016/j.addbeh.2012.10.002.
  • Bell, S., B. Partridge, J. Lucke, and W. Hall. 2013. “Australian University Students’ Attitudes Towards the Acceptability and Regulation of Pharmaceuticals to Improve Academic Performance.” Neuroethics 6: 197–205. doi:10.1007/s12152-012-9153-9.
  • Braun, V., and V. Clarke. 2006. “Using Thematic Analysis in Psychology.” Qualitative Research in Psychology 3 (2): 77–101. doi:10.1191/1478088706qp063oa.
  • Cheshire, W. P. 2006. “Drugs for Enhancing Cognition and Their Ethical Implications: A Hot New Cup of Tea.” Expert Review of Neurotherapeutics 6 (3): 263–266. doi:10.1586/14737175.6.3.263.
  • Corbin Dwyer, S., and J. L. Buckle. 2009. “The Space Between: On Being an Insider-Outsider in Qualitative Research.” International Journal of Qualitative Methods 8 (1): 54–63. doi:10.1177/160940690900800105.
  • d’Angelo, L., S. Camilla, G. Savulich, and B. J. Sahakian. 2017. “Lifestyle Use of Drugs by Healthy People for Enhancing Cognition, Creativity, Motivation and Pleasure.” British Journal of Pharmacology 174: 3257–3267. doi:10.1111/bph.13813.
  • Dearnley, C. 2005. “A Reflection on the Use of Semi-structured Interviews.” Nurse Researcher 13: 19–28. doi:10.7748/nr2005.07.13.1.19.c5997.
  • DeSantis, A., S. M. Noar, and E. M. Webb. 2009. “Nonmedical ADHD Stimulant Use in Fraternities.” Journal of Studies on Alcohol and Drugs 70 (6): 952–954. doi:10.1177/1087054710367621.
  • Franke, A. G., C. Bagusat, S. Rust, A. Engel, and K. Lieb. 2014. “Substances Used and Prevalence Rates of Pharmacological Cognitive Enhancement among Healthy Subjects.” European Archives of Psychiatry and Clinical Neuroscience 264 (1): 83–90. doi:10.1007/s00406-014-0537-1.
  • Hanson, C. L., S. H. Burton, C. Giraud-Carrier, J. H. West, M. D. Barnes, and B. Hansen. 2013. “Tweaking and Tweeting: Exploring Twitter for Nonmedical Use of a Psychostimulant Drug (Adderall) among College Students.” Journal of Medical Internet Research 15 (4): e62. doi:10.2196/jmir.2503.
  • Hodkinson, P. 2005. “‘Insider Research’ in the Study of Youth Cultures.” Journal of Youth Studies 8 (2): 131–149. doi:10.1080/13676260500149238.
  • Iorga, A. M., and N. A. Pop. 2017. “Ethical Dilemmas of Future Technologies.” In Ethics and Neuromarketing, Implications for Market Research and Business Practice, edited by A. R. Thomas, N. A. Pop, A. M. Iorga, and C. Ducu. Springer International Publishing Switzerland. doi:10.1007/978-3-319-45609-6.
  • Johnston, L. D., P. M. O’Malley, J. G. Bachman, J. E. Schulenberg, and R. A. Miech. 2016. Monitoring the future national survey results on drug use, 1975–2015: Volume II, college students and adults ages 19–55. Ann Arbor, MI: Institute for Social Research, The University of Michigan.
  • Kandel, D. B., K. Yamaguchi, and L. C. Klein. 2006. “Testing the Gateway Hypothesis.” Addiction 101 (4): 470–472. doi:10.1111/j.1360-0443.2006.01426.x.
  • Kay, T. 2016. “Knowledge, Not Numbers: Qualitative Research and Impact in Sport, Exercise and Health.” In Routledge Handbook of Qualitative Research in Sport and Exercise, edited by B. Smith and A. C. Sparkes, 424–437. London: Routledge.
  • Knapp, H., and S. A. Kirk. 2003. “Using Pencil and Paper, Internet and Touch-tone Phones for Self-administered Surveys: Does Methodology Matter?” Computers in Human Behavior 19 (1): 117–134. doi:10.1016/S0747-5632(02)00008-0.
  • Lakhan, S. E., and A. Kirchgessner. 2012. “Prescription Stimulants in Individuals with and without Attention Deficit Hyperactivity Disorder: Misuse, Cognitive Impact, and Adverse Effects.” Brain and Behavior 2 (5): 661–677. doi:10.1002/brb3.78.
  • London-Nadeau, K., P. Chan, and S. Wood. 2019. “Building Conceptions of Cognitive Enhancement: University Students’ Views on the Effects of Pharmacological Cognitive Enhancers.” Substance Use and Misuse 54: 908–920. doi:10.1080/10826084.2018.1552297.
  • Mache, S., P. Eickenhorst, K. Vitzthum, B. F. Klapp, and D. A. Groneberg. 2012. “Cognitive-enhancing Substance Use at German Universities: Frequency, Reasons and Gender Differences.” Wiener Medizinische Wochenschrift 162: 262–271. doi:10.1007/s10354-012-0115-y.
  • Maier, L. J., M. E. Liechti, F. Herzig, and M. P. Schaub. 2013. “To Dope or Not to Dope: Neuroenhancement with Prescription Drugs and Drugs of Abuse among Swiss University Students.” PLoS One 8 (11): e77967. doi:10.1371/journal.pone.0077967.
  • Micoulaud, J. A., A. MacGregor, and G. Fond. 2014. “A Preliminary Study on Cognitive Enhancer Consumption Behaviors and Motives of French Medicine and Pharmacology Students.” European Review for Medical and Pharmacological Sciences 18: 1875–1878.
  • Mohamed, A. D. 2014. “Reducing Creativity with Psychostimulants May Debilitate Mental Health and Well-Being.” Journal of Creativity in Mental Health 9: 146–163. doi:10.1080/15401383.2013.875865.
  • Nicholson, P. J., G. Mayho, and C. Sharp. 2015. “Cognitive Enhancing Drugs and the Workplace.” BMA. London. Accessed 08 November 2017. https://www.bma.org.uk/advice/employment/occupational-health/cognitive-enhancing-drugs
  • Norman, K. L., and T. Pleskac. 2002. “Conditional Branching in Computerized Self-administered Questionnaires on the World Wide Web.” Proceedings of the Human Factors and Ergonomics Society Annual Meeting 46 (14): 1241–1245. doi:10.1177/154193120204601401.
  • Partridge, B., S. Bell, J. Lucke, and W. Hall. 2013. “Australian University Students’ Attitudes Towards the Use of Prescription Stimulants as Cognitive Enhancers: Perceived Patterns of Use, Efficacy and Safety.” Drug and Alcohol Review 32 (3): 295–302. doi:10.1111/dar.12005.
  • Partridge, B. J., S. K. Bell, J. C. Lucke, S. Yeates, and W. D. Hall. 2011. “Smart Drugs “As Common as Coffee”: Media Hype about Neuroenhancement.” PLoS One 6 (11): e28416. doi:10.1371/journal.pone.0028416.
  • Patton, M. Q. 2002. Qualitative Research and Evaluation Methods. Thousand Oaks, CA: Sage.
  • Pliszka, S. R., R. G. Browne, R. L. Olvera, and S. K. Wynne. 2000. “A Double-blind, Placebo-controlled Study of Adderall and Methylphenidate in the Treatment of Attention-deficit/hyperactivity Disorder.” Journal of the American Academy of Child & Adolescent Psychiatry 39 (5): 619–626. doi:10.1097/00004583-200005000-00016.
  • Racine, E., and C. Forlini. 2010. “Cognitive Enhancement, Lifestyle Choice or Misuse of Prescription Drugs?” Neuroethics 3 (1): 1–4. doi:10.1007/s12152-008-9023-7.
  • Ragan, C. I., I. Bard, and I. Singh. 2013. “What Should We Do about Student Use of Cognitive Enhancers? An Analysis of Current Evidence.” Neuropharmacology 64: 588–595. doi:10.1016/j.neuropharm.2012.06.016.
  • Rami, S., S. Hussainy, M. Henning, M. Jensen, and B. Russell. 2016. “Prevalence of Cognitive Enhancer Use among New Zealand Tertiary Students.” Drug and Alcohol Review 35: 345–351. doi:10.1111/dar.12294.
  • Ramo, D. E., H. Liu, and J. J. Prochaska. 2012. “Reliability and Validity of Young Adults’ Anonymous Online Reports of Marijuana Use and Thoughts about Use.” Psychology of Addictive Behaviors 26 (4): 801–811. doi:10.1037/a0026201.
  • Riddell, C., C. Jensen, and O. Carter. 2018. “Cognitive Enhancement and Coping in an Australian University Student Sample.” Journal of Cognitive Enhancement 2: 63–69. doi:10.1007/s41465-017-0046-z.
  • Rodriguez, O. M. A. A. S., S. O. León, M. G. Simón, M. H. González, E. Á. de Morales Gómez-moreno, J. L. Fernández, … L. T. Gorgojo. 2016. “Tests Get Me Nervous: A Case of Pharmacological Enhancement.” European Psychiatry 33: S649. doi:10.1016/j.eurpsy.2016.01.1925.
  • Saletu, M. T., and G. Saletu-Zyhlarz. 2013. “Modafinil Effects in Narcolepsy.” In Neuroimaging of Sleep and Sleep Disorders, edited by E. Nofzinger, P. Maquet, and M. J. Thorpy, 231–239. Cambridge, England: Cambridge University Press.
  • Sattler, S., and C. Wiegel. 2013. “Cognitive Test Anxiety and Cognitive Enhancement: The Influence of Students’ Worries on Their Use of Performance-enhancing Drugs.” Substance Use & Misuse 48 (3): 220–232. doi:10.3109/10826084.2012.751426.
  • Schelle, K. J., B. M. J. Olthof, W. Reintjes, C. Bundt, J. Gusman-Vermeer, and A. C. C. M. van Mil. 2015. “A Survey of Substance Use for Cognitive Enhancement by University Students in the Netherlands.” Frontiers in System Neuroscience 9: 1–11. doi:10.3389/fnsys.2015.00010.
  • Singh, I., I. Bard, and J. Jackson. 2014. “Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement among University Students in the UK and Ireland.” PLoS One 9: 1–12. doi:10.1371/journal.pone.0105969.
  • Smith, M. E., and M. J. Farah. 2011. “Are Prescription Stimulants “Smart Pills”? The Epidemiology and Cognitive Neuroscience of Prescription Stimulant Use by Normal Healthy Individuals.” Psychological Bulletin 137 (5): 717–741. doi:10.1037/a0023825.
  • Stuckey, H. L. 2014. “The First Step in Data Analysis: Transcribing and Managing Qualitative Research Data.” Journal of Social Health and Diabetes 2 (1): 6–8. doi:10.4103/2321-0656.120254.
  • Sturges, J. E., and K. J. Hanrahan. 2004. “Comparing Telephone and Face-to-face Qualitative Interviewing: A Research Note.” Qualitative Research 4 (1): 107–118. doi:10.1177/1468794104041110.
  • Terrell, S. R. 2012. “Mixed-methods Research Methodologies.” The Qualitative Report 17 (1): 254–280.
  • Teter, C. J., S. E. McCabe, K. LaGrange, J. A. Cranford, and C. J. Boyd. 2006. “Illicit Use of Specific Prescription Stimulants among College Students: Prevalence, Motives, and Routes of Administration.” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (10): 1501–1510. doi:10.1592/phco.26.10.1501.
  • Turner, D. C., T. W. Robbins, L. Clark, A. R. Aron, J. Dowson, and B. J. Sahakian. 2003. “Cognitive Enhancing Effects of Modafinil in Healthy Volunteers.” Psychopharmacology 165 (3): 260–269. doi:10.1007/s00213-002-1250-8.
  • Van Hal, G., J. Rosiers, K. Ponnet, and E. Wouters. 2013. “Popping Smart Pills: Prescription Stimulant Misuse by University and College Students in Flanders.” European Journal of Public Health 23 (Suppl. 1): 122. doi:10.1093/eurpub/ckt126.300.
  • Vicente, P., and E. Reis. 2010. “Using Questionnaire Design to Fight Nonresponse Bias in Web Surveys.” Social Science Computer Review 28: 51–267. doi:10.1177/0894439309340751.
  • Webb, J. R., M. A. Valasek, and C. S. North. 2013. “Prevalence of Stimulant Use in a Sample of US Medical Students.” Annals of Clinical Psychiatry (2013 (25): 27–32.
  • Wilens, T. E., L. A. Adler, J. Adams, S. Sgambati, J. Rotrosen, R. Sawtelle, and S. Fusillo. 2008. “Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature.” Journal of the American Academy of Child & Adolescent Psychiatry 47 (1): 21–31. doi:10.1097/chi.0b013e31815a56f1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.